Thomas E. Ichim

6.7k total citations
126 papers, 5.1k citations indexed

About

Thomas E. Ichim is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Thomas E. Ichim has authored 126 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 48 papers in Immunology and 32 papers in Genetics. Recurrent topics in Thomas E. Ichim's work include Immunotherapy and Immune Responses (39 papers), Mesenchymal stem cell research (29 papers) and RNA Interference and Gene Delivery (19 papers). Thomas E. Ichim is often cited by papers focused on Immunotherapy and Immune Responses (39 papers), Mesenchymal stem cell research (29 papers) and RNA Interference and Gene Delivery (19 papers). Thomas E. Ichim collaborates with scholars based in United States, Canada and China. Thomas E. Ichim's co-authors include Neil H Riordan, Wei‐Ping Min, Xiufen Zheng, Santosh Kesari, Amit N. Patel, Mu Li, Vladimir Bogin, Kyle Chan, Robert Zhong and Zhaohui Zhong and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Thomas E. Ichim

124 papers receiving 4.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas E. Ichim 2.0k 1.7k 1.2k 1.1k 635 126 5.1k
Thomas Ritter 3.1k 1.5× 1.8k 1.1× 1.9k 1.6× 1.5k 1.3× 740 1.2× 141 7.2k
Wei Cao 2.5k 1.3× 1.5k 0.9× 1.3k 1.1× 818 0.7× 1.5k 2.3× 146 5.8k
Riichiro Abe 1.5k 0.8× 1.6k 1.0× 876 0.7× 692 0.6× 331 0.5× 167 6.5k
Stefania Morrone 1.6k 0.8× 1.9k 1.2× 456 0.4× 1.0k 0.9× 296 0.5× 126 5.0k
Cécile V. Denis 1.9k 0.9× 2.0k 1.2× 943 0.8× 1.0k 0.9× 353 0.6× 188 8.8k
Thomas Häupl 1.4k 0.7× 859 0.5× 1.0k 0.9× 648 0.6× 442 0.7× 105 4.4k
Peter L. E. M. van Lent 2.3k 1.2× 1.8k 1.1× 465 0.4× 680 0.6× 894 1.4× 129 6.1k
Andy Peng Xiang 2.8k 1.4× 740 0.4× 1.9k 1.6× 1.2k 1.0× 691 1.1× 161 6.1k
Marco Marchisio 2.5k 1.2× 638 0.4× 854 0.7× 810 0.7× 694 1.1× 162 5.0k
Dietmar Pfeifer 2.2k 1.1× 3.2k 1.9× 685 0.6× 1.2k 1.0× 669 1.1× 128 6.6k

Countries citing papers authored by Thomas E. Ichim

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Ichim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Ichim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Ichim more than expected).

Fields of papers citing papers by Thomas E. Ichim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Ichim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Ichim. The network helps show where Thomas E. Ichim may publish in the future.

Co-authorship network of co-authors of Thomas E. Ichim

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Ichim. A scholar is included among the top collaborators of Thomas E. Ichim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Ichim. Thomas E. Ichim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ichim, Thomas E., Gilberto Lopes, Boris Minev, et al.. (2025). Reduction of solid tumors by senescent cell immunization. Journal of Translational Medicine. 23(1). 1365–1365.
2.
Ichim, Thomas E., et al.. (2025). Reversing coma by senolytics and stem cells: the future is now. Journal of Translational Medicine. 23(1). 1060–1060.
4.
Lin, Feng, Thomas E. Ichim, Joyce Hu, et al.. (2023). Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines. Journal of Translational Medicine. 21(1). 830–830. 17 indexed citations
5.
Riordan, Neil H, Thomas E. Ichim, Hong Ma, et al.. (2016). Safety of targeting tumor endothelial cell antigens. Journal of Translational Medicine. 14(1). 90–90. 7 indexed citations
6.
Zheng, Xiufen, James Koropatnick, Di Chen, et al.. (2012). Silencing IDO in dendritic cells: A novel approach to enhance cancer immunotherapy in a murine breast cancer model. International Journal of Cancer. 132(4). 967–977. 91 indexed citations
7.
Ichim, Thomas E., Boris Minev, Todd A. Braciak, et al.. (2011). Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?. Journal of Translational Medicine. 9(1). 25–25. 22 indexed citations
8.
Alexandrescu, Doru T, Neil H Riordan, Thomas E. Ichim, et al.. (2011). On the missing link between inflammation and cancer. Dermatology Online Journal. 17(1). 10–10. 25 indexed citations
9.
Min, Wei‐Ping, et al.. (2010). RNA Interference. Methods in molecular biology. 1 indexed citations
10.
Mansilla, Eduardo, Gustavo H. Marín, Luis Núñez, et al.. (2010). The Lysosomotropic Agent, Hydroxychloroquine, Delivered in a Biodegradable Nanoparticle System, Overcomes Drug Resistance of B-Chronic Lymphocytic Leukemia Cells In Vitro. Cancer Biotherapy and Radiopharmaceuticals. 25(1). 97–103. 14 indexed citations
11.
Zheng, Xiufen, Motohiko Suzuki, Thomas E. Ichim, et al.. (2010). Treatment of Autoimmune Arthritis Using RNA Interference-Modulated Dendritic Cells. The Journal of Immunology. 184(11). 6457–6464. 49 indexed citations
12.
Wang, Hao, Wei Ge, Jacqueline Arp, et al.. (2009). Free Bone Graft Attenuates Acute Rejection and in Combination with Cyclosporin A Leads to Indefinite Cardiac Allograft Survival. The Journal of Immunology. 182(10). 5970–5981. 6 indexed citations
13.
Zheng, Xiufen, Xusheng Zhang, Biao Feng, et al.. (2008). Gene Silencing of Complement C5a Receptor Using siRNA for Preventing Ischemia/Reperfusion Injury. American Journal Of Pathology. 173(4). 973–980. 83 indexed citations
14.
Kanai, Nobuyuki, Wei‐Ping Min, Thomas E. Ichim, Hao Wang, & Robert Zhong. (2007). Th1/Th2 xenogenic antibody responses are associated with recipient dendritic cells. Microsurgery. 27(4). 234–239. 11 indexed citations
15.
Ghochikyan, Anahit, Mikayel Mkrtichyan, Dmitri Loukinov, et al.. (2007). Elicitation of T Cell Responses to Histologically Unrelated Tumors by Immunization with the Novel Cancer-Testis Antigen, Brother of the Regulator of Imprinted Sites. The Journal of Immunology. 178(1). 566–573. 26 indexed citations
16.
Tuchin, Valery V., et al.. (2006). Experimental study of NIR transmittance of the human skull. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 6085. 60850T–60850T. 13 indexed citations
17.
Li, Mu, Hua Qian, Thomas E. Ichim, et al.. (2004). Induction of RNA Interference in Dendritic Cells. Immunologic Research. 30(2). 215–230. 19 indexed citations
18.
Min, Wei‐Ping, Dejun Zhou, Thomas E. Ichim, et al.. (2003). Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance. The Journal of Immunology. 170(3). 1304–1312. 211 indexed citations
19.
Hill, Jonathan A., Thomas E. Ichim, Mu Li, et al.. (2003). Immune Modulation by Silencing IL-12 Production in Dendritic Cells Using Small Interfering RNA. The Journal of Immunology. 171(2). 691–696. 107 indexed citations
20.
Wang, Hao, Wei‐Ping Min, Jinming Yang, et al.. (2003). Cytokines Regulate the Pattern of Rejection and Susceptibility to Cyclosporine Therapy in Different Mouse Recipient Strains After Cardiac Allografting. The Journal of Immunology. 171(7). 3823–3836. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026